Presented in a poster at the 2026 MDA Clinical & Scientific Conference, the approval is supported by data from the Phase 3 ADAPT SERON study, a randomized, double-blind, placebo-controlled trial ...

Chris Finister, 52, from Evenley, will take part in the Bidwells Oxford 10k this Sunday, May 10, in support of his partner Liz Williams, also 52, who was diagnosed with facioscapulohumeral muscular ...

Achieved the primary objective with favorable safety and tolerability, no discontinuations and no serious adverse events -- - ...

Givinostat will be made available to eligible patients with Duchenne muscular dystrophy after its manufacturer struck a ...

Capricor Therapeutics has accused Nippon Shinyaku and its U.S. subsidiary of botching the rollout of a Duchenne muscular ...

Managing the transition to mobility aids is a pivotal part of life with DMD. Discover expert strategies for maintaining ...

The muscular dystrophies represent disorders of progressive muscular degeneration and weakness. As a group, they exhibit clinical heterogeneity that reflects diverse molecular mechanisms responsible ...

For Duchenne and Becker muscular dystrophies, muscle biopsy may show whether dystrophin, a muscle protein, is missing or abnormal, and DNA testing is used to analyze the condition of the related gene.

Entrada said Thursday that Cohort 1 demonstrated an increase of 2.36% in dystrophin over a baseline of 4% and an increase of 2.31% in exon skipping over a baseline of 2.66% in treated participants.

At 59, Frampton experienced the first symptoms of IBM, a degenerative muscle disease, which he publicly revealed in 2019 ...

Muscular dystrophy (MD) is a group of genetic diseases that cause your muscles to progressively weaken and degenerate. There are several types of MD, each with its own symptoms, but they all involve ...

Chris Finister, 52, from Evenley, will take part in the Bidwells Oxford 10k this Sunday, May 10.